These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 10663973)
1. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Masliah E Acta Neuropathol; 2000 Mar; 99(3):296-304. PubMed ID: 10663973 [TBL] [Abstract][Full Text] [Related]
2. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660 [TBL] [Abstract][Full Text] [Related]
3. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342 [TBL] [Abstract][Full Text] [Related]
7. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907 [TBL] [Abstract][Full Text] [Related]
8. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385 [TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
12. The prion protein in human neurodegenerative disorders. Kovacs GG; Zerbi P; Voigtländer T; Strohschneider M; Trabattoni G; Hainfellner JA; Budka H Neurosci Lett; 2002 Sep; 329(3):269-72. PubMed ID: 12183028 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Lee SS; Kim YM; Junn E; Lee G; Park KH; Tanaka M; Ronchetti RD; Quezado MM; Mouradian MM Neurobiol Aging; 2003 Sep; 24(5):687-96. PubMed ID: 12885576 [TBL] [Abstract][Full Text] [Related]
17. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Takeda A; Mallory M; Sundsmo M; Honer W; Hansen L; Masliah E Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Wakabayashi K; Hayashi S; Kakita A; Yamada M; Toyoshima Y; Yoshimoto M; Takahashi H Acta Neuropathol; 1998 Nov; 96(5):445-52. PubMed ID: 9829807 [TBL] [Abstract][Full Text] [Related]
19. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387 [TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification. Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]